Source: https://journal.niidi.ru/jofin/article/view/53
Timestamp: 2019-04-20 22:10:59+00:00

Document:
1. Якобсон, И.М. Внепеченочные проявления хронического гепатита С / И.М. Якобсон [и др.] // Клин. гастроэнтерол. и гепатол. – 2011. – Т. 4, № 1. – С. 55–68.
2. Zignego, A.L. Extrahepatic manifestations of hepatitis C virus infection: A general overview and guidelines for a clinical approach / A.L. Zignego [et al.] // Dig. Liver Dis. – 2007. – V. 39. – P. 2–17.
3. Monti, G. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias / G. Monti [et al.] // Arch. Intern. Med. – 2005. – V. 165. – P. 101–105.
4. Fabrizi, F. Therapy of hepatitis C virus-associated glomerulonephritis: Current approaches / F. Fabrizi [et al.] // J. Nephrol. – 2008. – V. 21. – P. 813–825.
5. Harrison, S.A. Insulin resistance among patients with chronic hepatitis C: Etiology and impact on treatment / S.A. Harrison // Clin. Gastroenterol. Hepatol. – 2008. – V. 6.– P. 864–876.
6. Moucari, R. Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis / R. Moucari [et al.] // Gastroenterol. – 2008. – V. 134. – P. 416–423.
7. Wang, C.S. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study /C.S. Wang [et al.] // Am. J. Epidemiol. – 2007. – V. 166. – P. 196–203.
8. Hsu, F.C. Prevalence of rheumatoid arthritis and hepatitis C in those age 60 and older in a US population based study / F.C. Hsu [et al.] // J. Rheumatol. – 2003. – V. 30. – P. 455–458.
9. Fox, R.I. Sjogren’s syndrome / R.I. Fox // Lancet. – 2005. – V. 366. – P. 321–331.
10. Leigh, J.P. Costs of hepatitis C / J.P. Leigh [et al.] //Arch. Intern. Med. – 2001. – V. 161. – P. 2231–2237.
11. Casato, M. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: A multicenter case-control study using magnetic resonance imaging and neuropsychological tests / M. Casato [et al.] //J. Rheumatol. – 2005. – V. 32. – P. 484–488.
12. Spiegel, B.M. Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment /B.M. Spiegel [et al.] // Hepatology. – 2005. – V. 41. – P. 790–800.
13. Cacoub, P. Cryoglobulinemia vasculitis / P. Cacoub [et al.] // Curr. Opin. Rheumatol. – 2002. – V. 14, № 1. – P. 29–35.
14. Ferri, C. Cryoglobulins / C. Ferri, A.L. Zignego, S.A. Pileri // J. Clin. Pathol. – 2002. – V. 55, № 1. – P. 413.
15. Younossi, Z. The effects of HCV infection and management on health-related quality of life / Z. Younossi, J. Kallman // J. Hepatol. – 2007. – V. 45. – P. 806–816.
16. Ferri, C. Cryoglobulinemic vasculitis / C. Ferri, M.T. Mascia // Curr. Opin. Rheumatol. – 2006. – V. 18. – P. 54–63.
17. Saadoun, D. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis / D. Saadoun [et al.] // Curr. Opin. Rheumatol. – 2008. – V. 20. – P. 23–28.
18. Saadoun, D. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy / D. Saadoun [et al.] // Rheumatol. – 2005. – V. 46. – P. 2917–2925.
19. Saadoun, D. Hepatitis C-associated mixed cryoglobulinemia: A crossroad between autoimmunity and lymphoproliferation / D. Saadoun [et al.] // Rheumatol. – 2007. – V. 52. – P. 1234–1242.
20. Cacoub, P. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: Where do we stand? / P. Cacoub [et al.] // Ann. Rheum. Dis. – 2008. – V. 67. – P. 283–287.
21. Cavallo, R. Rituximab in cryoglobulinemic peripheral neuropathy / R. Cavallo [et al.] // J. Neurol. – 2009. – V. 256. – P. 1076–1082.
22. Saadoun, D. Rituximab plus peg-interferon/ribavirin compared to αpeg-interferon/ribavirin in hepatitis C related mixedα cryoglobulinemia / D. Saadoun [et al.] // Blood. – 2010. – V. 116. – P. 326–334.
23. Lamprecht, P. Cryoglobulinemic vasculitis /P. Lamprecht, A. Gause, W.L. Gross // Arthritis and rheumatism. – 1999. – V. 42, № 12. – P. 2507–2516.
24. Тишкевич, О.А. Системный цитомегаловирусный васкулит у ВИЧ-инфицированного больного / О.А. Тишкевич [и др.] // Эпидемиология и инфекционные болезни. – 2001. – № 1. – С. 31–36.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.